1. Home
  2. ICFI vs EYPT Comparison

ICFI vs EYPT Comparison

Compare ICFI & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$89.73

Market Cap

1.3B

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$5.43

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICFI
EYPT
Founded
1969
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2006
2005

Fundamental Metrics

Financial Performance
Metric
ICFI
EYPT
Price
$89.73
$5.43
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$99.25
$31.80
AVG Volume (30 Days)
207.7K
5.1M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
0.82%
N/A
EPS Growth
N/A
N/A
EPS
2.61
N/A
Revenue
$1,229,162,000.00
$7,539,000.00
Revenue This Year
$4.12
N/A
Revenue Next Year
$5.33
$3,115.57
P/E Ratio
$34.13
N/A
Revenue Growth
3.72
N/A
52 Week Low
$58.83
$3.95
52 Week High
$101.50
$19.11

Technical Indicators

Market Signals
Indicator
ICFI
EYPT
Relative Strength Index (RSI) 60.23 29.52
Support Level $84.28 N/A
Resistance Level $89.91 $15.17
Average True Range (ATR) 3.34 0.91
MACD -0.31 -0.86
Stochastic Oscillator 53.91 12.07

Price Performance

Historical Comparison
ICFI
EYPT

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions, including management, technology and policy consulting and implementation services, to government and commercial clients in the U.S. and internationally. Its government clients include U.S. federal agencies, state and local governments and international governments, as well as commercial clients inside and outside the U.S. It supports clients in Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs; and Security and Other Civilian and Commercial markets. The company delivers services across the life cycle of a policy, program or project through Advisory Services, Program Implementation, Analytics Services, Digital Services and Engagement Services.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: